RiskReversal Pod cover image

A Monkey Wrench In The Market + Liz Ann Sonders on Her Second Half Outlook

RiskReversal Pod

00:00

Market Shift and Stock Performance of Weight Loss Companies

Discussion on the recent decline in Eli Lilly and Novo Nordisk stocks due to a Roche study impact, emphasizing concerns over premium valuations. Analysis on market cap, revenue numbers, and growth projections for Eli Lilly, along with a look at stock trading metrics and market movements including geopolitical effects and anticipation of tech earnings.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app